JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258035

Human LTB4R2 (Leukotriene B4 Receptor 2) knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

LTB4R2 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 22 bp deletion in exon2.

View Alternative Names

BLT2R, JULF2, LT4R2_HUMAN, LTB4 receptor JULF2, LTB4-R 2, Leukotriene B4 receptor 2, Leukotriene B4 receptor BLT2, Seven transmembrane receptor BLTR2

1 Images
Sanger Sequencing - Human LTB4R2 (Leukotriene B4 Receptor 2) knockout HeLa cell lysate (AB258035)
  • Sanger seq

Unknown

Sanger Sequencing - Human LTB4R2 (Leukotriene B4 Receptor 2) knockout HeLa cell lysate (AB258035)

Homozygous : 22 bp deletion in exon2

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 22 bp deletion in exon2.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258035-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human LTB4R2 knockout HeLa cell lysate", "number":"AB258035-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB258035-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
LTB4R2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Leukotriene B4 Receptor 2 (BLT2) also known as LTB4R2 plays an important mechanical role as a G-protein coupled receptor (GPCR) that binds leukotriene B4 (LTB4) a pro-inflammatory lipid mediator. BLT2 has a molecular mass of approximately 41 kDa and exhibits expression notably in tissues such as the spleen liver and intestinal tract. Alternative names for this receptor include BLTR2 or GPR43. It functions as part of the rapid cellular response in these tissues during immune reactions.
Biological function summary

The receptor BLT2 significantly contributes to the regulation of inflammatory responses. This receptor does not form part of a functional complex but operates independently to mediate chemotaxis and aggregation of immune cells like neutrophils. By interacting with leukotriene B4 BLT2 facilitates diverse immune responses including leukocyte recruitment and activation. Such activities underline its importance in acute inflammatory reactions and pathogen defense mechanisms.

Pathways

BLT2 influences and integrates into key cellular signaling routes such as the MAPK/ERK and PI3K/Akt pathways. These pathways affect cellular processes like proliferation survival and differentiation. BLT2's interaction with proteins involved in these pathways like ERK (Extracellular Signal-Regulated Kinases) or Akt (protein kinase B) demonstrate its role in amplifying and regulating immune responses during prolonged inflammation.

BLT2 has associations with inflammatory diseases including asthma and rheumatoid arthritis. These conditions involve chronic inflammation where BLT2 together with proteins like cytokines and other chemoattractant receptors exacerbates cellular recruitment and inflammatory signaling. By linking hyperactive immune cell responses BLT2 serves as a potential target in moderating disease manifestations and developing anti-inflammatory leukotriene-based therapies.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com